CPC A61K 31/496 (2013.01) [A61K 31/381 (2013.01); A61K 31/427 (2013.01); A61K 31/4965 (2013.01); A61K 31/675 (2013.01); A61K 31/7048 (2013.01); A61K 31/7068 (2013.01); A61K 35/16 (2013.01); A61K 39/3955 (2013.01); A61K 39/42 (2013.01); A61P 31/14 (2018.01); C07K 16/40 (2013.01); C12N 15/1137 (2013.01); G01N 33/5008 (2013.01); C12N 2310/14 (2013.01)] | 19 Claims |
1. A method of treating a severe acute respiratory syndrome (SARS) virus infection, the method comprising administering to a subject in need thereof, a composition comprising a protein disulfide isomerase (PDI) inhibitor and a pharmaceutically acceptable excipient.
|